Myriad Genetics to Sell Prenatal Testing Business to Labcorp for $210 Million
Myriad Genetics agrees to sell its Prenatal Health testing business, including Prequel and Foresight, to Labcorp for $210 million, closing by early 2027.
Already have an account? Sign in.